SCHEMBL6203955

SCHEMBL6203955

Cc1ccc(Cl)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12679 1.00
Fluoride SCHEMBL7653631 0.96 CES2 (0.59)
Phosphine SCHEMBL22129260 0.96
Water SCHEMBL28525892 0.96
Bromide SCHEMBL28687084 0.96 CES2 (0.59)
SCHEMBL31378075 0.96
Hydrochloric Acid SCHEMBL8996220 0.96
SCHEMBL4451559 0.96
Hydrochloric Acid SCHEMBL28895685 0.96 CES2 (0.59)
Water SCHEMBL9771893 0.96 CES2 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017463-B2 Inhibitors of deubiquitinating proteases BRANDEIS UNIVERSITY (US) 2018-07-10 US disclosed
US-20170204055-A1 INHIBITORS OF DEUBIQUITINATING PROTEASES BRANDEIS UNIVERSITY (US) 2017-07-20 US disclosed
WO-2016014522-A1 INHIBITORS OF DEUBIQUITINATING PROTEASES BRANDEIS UNIVERSITY (US) 2016-01-28 WO disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed
EP-0280927-A1 Mono- and diepoxide derivatives of delta 22-LL-F28249 compounds AMERICAN CYANAMID COMPANY (US) 1988-09-07 EP disclosed